What role for statins? A review and economic model.
Health Technology Assessment1999Vol. 3(19), pp. i–iv, 1
Citations Over TimeTop 10% of 1999 papers
Ebrahim, George Davey Smith, McCabe, Payne, Pickin, T. Sheldon, Fiona Lampe, Fiona Sampson, Sue Ward, S. Goya Wannamethee
Abstract
T he overall aim of the NHS R&D Health Technology Assessment (HTA) programme is to ensure that high-quality research information on the costs, effectiveness and broader impact of health technologies is produced in the most efficient way for those who use, manage and work in the NHS. Research is undertaken in those areas where the evidence will lead to the greatest benefits to patients, either through improved patient outcomes or the most efficient use of NHS resources.
Related Papers
- → What is technology assessment?(2009)167 cited
- → Health technology assessment(2009)21 cited
- → Health technology assessment(2010)13 cited
- → Medical technology assessment and the role of economic evaluation in health care(1996)9 cited
- Medical technology assessment: economic evaluation of new technologies.(1995)